Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma

A. Dodero,A. Guidetti,A. Tucci,F. Barretta,M. Novo,L. Devizzi,A. Re,A. Passi,A. Pellegrinelli,G. Pruneri, R. Miceli,A. Testi,M. Pennisi, M. C. Di Chio, P. Matteucci,C. Carniti,F. Facchetti, G. Rossi,P. Corradini

LEUKEMIA（2019）

引用 32|浏览90

暂无评分

关键词

Combination drug therapy,Drug development,Medicine/Public Health,general,Internal Medicine,Intensive / Critical Care Medicine,Cancer Research,Oncology,Hematology

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要